Cell-Specific Regulation of Oncogene-Responsive Sequences of the c-fos Promoter

References

• Angel, P., K. Hattori, T. Smeal, and M. Karin. 1988. The jun proto-oncogene is positively autoregulated by its product, jun/ API. Cell 55:875-885.
   PubMed Web of Science ®Google Scholar
• Chavrier, P., U. Janssen-Timmen, M. G. Mattel, M. Zerial, R. Bravo, and P. Charnay. 1989. Structure, chromosomal location, and expression of the mouse zinc finger gene Krox-20: multiple gene products and coregulation with the proto-oncogene c-fos. Mol. Cell. Biol. 9:787-797.
   PubMed Web of Science ®Google Scholar
• Christy, B. A., L. F. Lau, and D. Nathans. 1988. Functional serum response elements upstream of the growth factor inducible zif268. Proc. Natl. Acad. Sci. USA 85:7857-7861.
   PubMed Web of Science ®Google Scholar
• Curran, T. 1988. The fos oncogene, p. 51-70. In E. P. Reddy, A. M. Skalka, and T. Curran (ed.), The oncogene handbook. Elsevier, Amsterdam.
   Google Scholar
• Fisch, T. M., R. Prywes, and R. G. Roeder. 1989. An API-binding site in the c-fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoyl phorbol-13-acetate. Mol. Cell. Biol. 9:1327-1331.
   PubMed Web of Science ®Google Scholar
• Gilman, M. Z. 1988. The c-fos SRE responds to protein kinase C dependent and independent signals but not to cyclic AMP. Genes Dev. 2:394-402.
   PubMed Web of Science ®Google Scholar
• Gius, D., X. Cao, F. J. Rauscher III, D. R. Cohen, T. Curran, and V. P. Sukhatme. 1990. Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early expression via CArG elements. Mol. Cell. Biol. 10:4243-4255.
   PubMed Web of Science ®Google Scholar
• Graham, R., and M. Gilman. 1991. Distinct protein targets for signals acting at the c-fos serum response element. Science 251:189-192.
   PubMedGoogle Scholar
• Green, S., I. Isseman, and E. Sheer. 1988. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:369.
   PubMedGoogle Scholar
• Greenberg, M. E., Z. Sigfried, and E. B. Ziff. 1987. Mutation of the c-fos gene dyad symmetry element inhibits serum inducibility of transcription in vivo and the nuclear regulatory factor binding in vitro. Mol. Cell. Biol. 7:1217-1225.
   PubMed Web of Science ®Google Scholar
• Gutman, A., and B. Wasylyk. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J. 9:2241-2246.
   PubMed Web of Science ®Google Scholar
• Gutman, A., and B. Wasylyk. 1991. Nuclear targets for transcription regulation by oncogenes. Trends Genet. 7:49-54.
   PubMedGoogle Scholar
• Hayes, T. E., P. Sengupta, and B. H. Cochran. 1988. The human c-fos serum response factor and the yeast factors GRM/PRTF have related DNA-binding specificities. Genes Dev. 2:1713-1722.
   PubMedGoogle Scholar
• Herrera, R. E., P. E. Shaw, and A. Nordheim. 1989. Occupation of the c-fos serum response element in vivo by a multiprotein complex is unaltered by growth factor induction. Nature (London) 340:68-70.
   PubMedGoogle Scholar
• Jamal, S., and E. Ziff. 1990. Transactivation of c-fos and β-actin genes by raf as a step in early response to transmembrane signals. Nature (London) 344:463-466.
   PubMed Web of Science ®Google Scholar
• Jarvis, E. E., K. L. Clark, and G. F. Sprague, Jr. 1989. The yeast transcription activator PRTF, a homolog of the mammalian serum response factor, is encoded by the MCM1 gene. Genes Dev. 3:936-945.
   PubMed Web of Science ®Google Scholar
• König, H., H. Ponta, U. Rahmsdorf, M. Büscher, A. Schöntal, H. J. Rahmsdorf, and P. Herrlich. 1989. Autoregulation of fos: the dyad symmetry element as the major target of repression. EMBO J. 8:2559-2566.
   PubMedGoogle Scholar
• Leung, S., and N. G. Miyamoto. 1989. Point mutational analysis of the human c-fos serum response factor binding site. Nucleic Acids Res. 17:1177-1194.
   PubMedGoogle Scholar
• Lucibello, F. C., C. Lowag, M. Neuberg, and R. Muller. 1989. Trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation. Cell 59:999-1007.
   PubMedGoogle Scholar
• Manak, R., N. Bischop, R. M. Kris, and R. Prywes. 1990. Casein-kinase II enhances the DNA binding activity of serum response factor. Genes Dev. 4:955-967.
   PubMedGoogle Scholar
• Norman, C., M. Runswick, R. Pollock, and R. Treisman. 1988. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 55:989-1003.
   PubMed Web of Science ®Google Scholar
• Passmore, S., R. Elble, and T. Bik-Kwoon. 1989. A protein involved in minichromosome maintenance in yeast binds a transcriptional enhancer conserved in eukaryotes. Genes Dev. 3:921-935.
   PubMedGoogle Scholar
• Prywes, R., and R. G. Roeder. 1987. Purification of the c-fos enhancer-binding protein. Mol. Cell. Biol. 7:3482-3489.
   PubMed Web of Science ®Google Scholar
• Rivera, V., and M. E. Greenberg. 1990. Growth factor-induced gene expression: the ups and downs of c-fos regulation. New Biol. 2:751-758.
   PubMedGoogle Scholar
• Rivera, V. M., M. Sheng, and M. E. Greenberg. 1990. The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation. Genes Dev. 4:255-268.
   PubMedGoogle Scholar
• Ryan, W. A., Jr., R. B. Franza, and M. Z. Gilman. 1989. Two distinct cellular phosphoproteins bind to the c-fos serum response element. EMBO J. 8:1785-1792.
   PubMed Web of Science ®Google Scholar
• Schonthal, A., and J. R. Feramisco. 1990. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product. New Biol. 2:143-150.
   PubMedGoogle Scholar
• Shaw, P. E., S. Frasch, and A. Nordheim. 1989. Repression of c-fos transcription is mediated through p67SRF bound to the SRE. EMBO J. 8:2567-2574.
   PubMedGoogle Scholar
• Shaw, P. E., H. Schroter, and A. Nordheim. 1989. The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the c-fos promoter. Cell 56:563-572.
   PubMed Web of Science ®Google Scholar
• Sheng, M., S. T. Dougan, G. McFadden, and M. E. Greenberg. 1988. Calcium and growth factor induced pathways of c-fos transcriptional activation require different upstream regulatory sequences. Mol. Cell. Biol. 8:2787-2796.
   PubMedGoogle Scholar
• Stacey, D. W., T. Watson, H.-F. Rung, and T. Curran. 1987. Microinjection of transforming ras protein induces c-fos expression. Mol. Cell. Biol. 7:523-527.
   PubMedGoogle Scholar
• Stumpo, D., T. N. Stewart, M. Z. Gilman, and P. J. Blackshear. 1988. Identification of c-fos sequences involved in induction by insulin and phorbol esters. J. Biol. Chem. 263:1611-1616.
   PubMed Web of Science ®Google Scholar
• Treisman, R. 1986. Identification of a protein-binding site that mediates transcription response of the c-fos gene to serum factors. Cell 46:567-574.
   PubMed Web of Science ®Google Scholar
• Treisman, R. 1990. The SRE: a growth factor responsive transcriptional regulator. Cancer Biol. 1:47-58.
   PubMedGoogle Scholar
• Velcich, A., and E. B. Ziff. 1990. Functional analysis of an isolated fos promoter element with AP-1 site homology reveals cell type-specific transcriptional properties. Mol. Cell. Biol. 10:6273-6282.
   PubMedGoogle Scholar
• Walsh, K. 1989. Cross-binding of factors to functionally different promoter elements in c-fos and skeletal actin genes. Mol. Cell. Biol. 9:2191-2201.
   PubMedGoogle Scholar
• Wasylyk, C., P. Flores, A. Gutman, and B. Wasylyk. 1989. PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes. EMBO J. 8:3371-3378.
   PubMedGoogle Scholar
• Wasylyk, C., J. L. Inder, and B. Wasylyk. 1988. Transforming but not immortalizing oncogenes activate the transcription factor PEA1. EMBO J. 7:2475-2483.
   PubMedGoogle Scholar
• Yu, S.-F., T. Rüden, P. W. Kantoff, C. Garber, M. Seiberg, U. Rüther, W. F. Anderson, E. F. Wagner, and E. Gilboa. 1986. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83:3194-3198.
   PubMed Web of Science ®Google Scholar